Park et al. demonstrated, using TNBC tumor xenograft in vivo models, that paclitaxel treatment increased TGF-β signalling and increased (by approximately four times) SNAI1 gene and protein expression following treatment. This evidence concerns the gene SNAI1 and neoplasm.